Cargando…

CAR‐NK cell in cancer immunotherapy; A promising frontier

Chimeric antigen receptors (CARs) have a unique facet of synthetic biology and offer a paradigm shift in personalized medicine as they can use and redirect the patient's immune cells to attack cancer cells. CAR‐natural killer (NK) cells combine the targeted specificity of antigens with the subs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marofi, Faroogh, Abdul‐Rasheed, Omar F., Rahman, Heshu Sulaiman, Budi, Hendrik Setia, Jalil, Abduladheem Turki, Yumashev, Alexei Valerievich, Hassanzadeh, Ali, Yazdanifar, Mahboubeh, Motavalli, Roza, Chartrand, Max Stanley, Ahmadi, Majid, Cid‐Arreguid, Angel, Jarahian, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409419/ https://www.ncbi.nlm.nih.gov/pubmed/34050690 http://dx.doi.org/10.1111/cas.14993

Ejemplares similares

A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
por: Moghadasi, Soudeh, et al.
Publicado: (2021)

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021)

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
por: Marofi, Faroogh, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy
por: Hassanzadeh, Ali, et al.
Publicado: (2021)

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy
por: Marofi, Faroogh, et al.
Publicado: (2021)

The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
por: Zeinalzadeh, Elham, et al.
Publicado: (2021)

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
por: Marofi, Faroogh, et al.
Publicado: (2021)

A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
por: Razeghian, Ehsan, et al.
Publicado: (2021)

Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities
por: Hassanzadeh, Ali, et al.
Publicado: (2021)

Cloning and Embryo Splitting in Mammalians: Brief History, Methods, and Achievements
por: Rahbaran, Mohaddeseh, et al.
Publicado: (2021)

Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
por: Widjaja, Gunawan, et al.
Publicado: (2021)

Expression of concern: “Humoral immune mechanisms involved in protective and pathological immunity during COVID-19” [Hum. Immunol. 82(10) (2021) 733–745]
por: Widjaja, Gunawan, et al.
Publicado: (2023)

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
por: Markov, Alexander, et al.
Publicado: (2021)

Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022)

Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape
por: Jarahian, Mostafa, et al.
Publicado: (2021)

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
por: Sajjadi-Dokht, Mehdi, et al.
Publicado: (2021)

Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
por: Morandi, Fabio, et al.
Publicado: (2020)

Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
por: Budi, Hendrik Setia, et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
por: Razeghian, Ehsan, et al.
Publicado: (2021)

Up‐regulation of KISS1 as a novel target of Let‐7i in melanoma serves as a potential suppressor of migration and proliferation in vitro
por: Alkafaji, Haider A., et al.
Publicado: (2021)

Gastrointestinal Involvement in Long COVID and Potential Pathogenic Mechanisms
por: Jadali, Zohreh, et al.
Publicado: (2022)

Long COVID and ophthalmology: New insights into underlying disease mechanisms
por: Jadali, Zohreh, et al.
Publicado: (2022)

Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol
por: Nakhaei, Pooria, et al.
Publicado: (2021)

Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
por: Shokouhifar, Alireza, et al.
Publicado: (2021)

Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
por: Shomali, Navid, et al.
Publicado: (2022)

A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
por: Mohammed, Rebar N., et al.
Publicado: (2022)

The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
por: Rajabi, Sadegh, et al.
Publicado: (2021)

NK cells blur the frontier between innate and acquired immunity
por: Terrazzano, Giuseppe, et al.
Publicado: (2013)

Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer
por: Marofi, Faroogh, et al.
Publicado: (2017)

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
por: Slepicka, Priscila Ferreira, et al.
Publicado: (2021)

Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature
por: Aravindhan, Surendar, et al.
Publicado: (2021)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

Antihypercholesterolemic and antioxidant efficacies of zerumbone on the formation, development, and establishment of atherosclerosis in cholesterol-fed rabbits
por: Hemn, Hassan Othman, et al.
Publicado: (2015)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ilj2np5hmqoqvvhngv3orl3lrq